{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2017", "item": "https://www.patentleaderboard.com/2017/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2017/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Joel Bard", "item": "https://www.patentleaderboard.com/2017/inventor/fl:jo_ln:bard-7"}]}

Home › 2017 › Pfizer › Joel Bard

Joel Bard — 1 Patent in 2017

Bristol-Myers Squibb: 1 patents #273 of 620Top 45%

Pfizer: 1 patents #98 of 344Top 30%

Newton, MA: #219 of 525 inventorsTop 45%

Massachusetts: #4,682 of 13,044 inventorsTop 40%

Overall (2017): #373,021 of 506,227Top 75%

1 Patents 2017

Issued Patents 2017

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
9683998	Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof	Robert Arch, Jun Zhang, Michelle Madar, Tetsuya Ishino, William James Jonathan Finlay +6 more	2017-06-20	$769,842,000

Joel Bard — 1 Patent in 2017

Issued Patents 2017

Patent Widget